Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma

International Journal of Radiation Oncology, Biology, Physics

Volumn 12, Issue 12, 1986, Pages 2127-2130

  Hornback, Ned B ^a   Omura, George ^b   Major, Francis J ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN;

ADJUVANT CHEMOTHERAPY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; FEMALE GENITAL SYSTEM; HUMAN; LEIOMYOSARCOMA; MUSCLE; PRIORITY JOURNAL; RADIOTHERAPY; THERAPY; TREATMENT; UTERUS SARCOMA;

COMBINED MODALITY THERAPY; FEMALE; HUMAN; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SARCOMA; SUPPORT, U.S. GOV'T, P.H.S.; UTERINE NEOPLASMS;

EID: 0022967217     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(86)90011-8     Document Type: Article

References (16)

1. Sarcoma of the uterus: A clinical and pathologic study of 177 cases
2. Radiotherapy in the treatment of sarcomas of the corpus uteri
3. Adriamycin and bleomycin, alone and in combination, in gynecologic cancers
4. Carcinosarcoma of the uterus: A 50-year review of 32 cases (1917–1926)
5. Uterine sarcoma
6. Carcinosarcoma and mixed mesodermal tumor of the uterine corpus: Review of 49 cases
7. Mixed mesodermal sarcoma of the uterus
8. Undifferentiated tumors
9. Sarcomas ofthe uterus
10. The value of radiation therapy in uterine sarcoma
11. Adriamycin (NSC-12317) used alone and in combination for soft tissues and bony sarcomas
12. Evaluation of treatment for sarcomas of the uterus
13. Postirradiation sarcomas of the uterus
14. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: A Gynecologic Oncology Group Study
15. A randomized trial of adriamycin versus no adjuvant chemotherapy in stage I and 11 uterine sarcomas (Abstr.)
16. Sarcomas of the uterine corpus: Prognostic factors and treatment